Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells
- PMID: 7730348
- DOI: 10.1074/jbc.270.17.9709
Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells
Abstract
Vascular endothelial growth factor (VEGF) is a potent angiogenic factor and endothelial cell-specific mitogen that stimulates urokinase-type plasminogen activator (uPA) activity in vascular endothelial cells. Here, we report that VEGF increases the high affinity binding of uPA to the same cells and that this binding is prevented by a peptide corresponding to the uPA receptor (uPAR) binding growth factor-like domain of uPA. Ligand cross-linking, ligand blotting, and uPA-Sepharose affinity chromatography revealed an increase in a cell surface uPA binding protein that corresponds to the uPAR on the basis of its affinity for uPA, M(r) of 50,000-55,000, and phosphatidylinositol-specific phospholipase C sensitivity. By Scatchard analysis, VEGF increased the number of uPAR molecules by 2.8-3.5-fold and concomitantly decreased their affinity for uPA. By northern blotting uPAR mRNA was increased in a dose- and time-dependent manner in response to VEGF. Taken together, these findings demonstrate that VEGF-induced angiogenesis is accompanied by increased uPAR expression and uPA activity on the endothelial cell surface. These observations are consistent with the notion that the uPA-uPAR interaction facilitates cellular invasion.
Similar articles
-
VEGF-induced paracellular permeability in cultured endothelial cells involves urokinase and its receptor.FASEB J. 2003 Apr;17(6):752-4. doi: 10.1096/fj.02-0484fje. Epub 2003 Feb 19. FASEB J. 2003. PMID: 12594181
-
Urokinase receptor expression on human microvascular endothelial cells is increased by hypoxia: implications for capillary-like tube formation in a fibrin matrix.Blood. 2000 Oct 15;96(8):2775-83. Blood. 2000. PMID: 11023511
-
Tumor cell-conditioned medium stimulates expression of the urokinase receptor in vascular endothelial cells.J Cell Physiol. 1996 Nov;169(2):300-8. doi: 10.1002/(SICI)1097-4652(199611)169:2<300::AID-JCP9>3.0.CO;2-S. J Cell Physiol. 1996. PMID: 8908197
-
Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.Stem Cells. 1997;15(6):398-408. doi: 10.1002/stem.150398. Stem Cells. 1997. PMID: 9402652 Review.
-
Role of fibrin and plasminogen activators in repair-associated angiogenesis: in vitro studies with human endothelial cells.EXS. 1997;79:391-411. doi: 10.1007/978-3-0348-9006-9_16. EXS. 1997. PMID: 9002228 Review.
Cited by
-
Impact of tumor cell VEGF expression on the in vivo efficacy of vandetanib (ZACTIMA; ZD6474).Anticancer Res. 2009 Jun;29(6):1987-92. Anticancer Res. 2009. PMID: 19528456 Free PMC article.
-
Could Vitamin D Be Effective in Prevention of Preeclampsia?Nutrients. 2021 Oct 28;13(11):3854. doi: 10.3390/nu13113854. Nutrients. 2021. PMID: 34836111 Free PMC article. Review.
-
[Urine-based markers of angiogenesis in bladder cancer].Urologe A. 2009 Jun;48(6):609-14. doi: 10.1007/s00120-009-1989-1. Urologe A. 2009. PMID: 19557465 Review. German.
-
VEGF-A in Cardiomyocytes and Heart Diseases.Int J Mol Sci. 2020 Jul 26;21(15):5294. doi: 10.3390/ijms21155294. Int J Mol Sci. 2020. PMID: 32722551 Free PMC article. Review.
-
Vascular endothelial growth factor and placenta growth factor in intrauterine growth-restricted fetuses and neonates.Mediators Inflamm. 2005 Oct 24;2005(5):293-7. doi: 10.1155/MI.2005.293. Mediators Inflamm. 2005. PMID: 16258196 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous